MedTrace Logo

Effectiveness of Deep Versus Moderate Neuromuscular Blockade

NCT03266419 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-11-13

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate the influence of depth of neuromuscular blockade during laparoscopic gastrectomy on postoperative pain in surgical patients allocated randomly to either deep or moderate neuromuscular blockade group with standard-pressure pneumoperitoneum of 13 mmHg.

Conditions

  • Neuromuscular Blockade

Interventions

DRUG

Deep NMB using rocuronium

* Drug: rocuronium * Bolus dose: 0.7 mg/kg * Continuous infusion : 0.8-1.2 mg/kg/h for maintaining deep NMB (post tetanic count 1-2) during operation.

DRUG

Moderate NMB using rocuronium

* Drug: rocuronium * Bolus dose: none * Continuous infusion: 0.2-0.6 mg/kg/h for maintaining moderate NMB (train of four 1-2) during operation.

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Byung-Moon Choi, Dr · Department of Anesthesiology and Pain Medicine, Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-28
Primary Completion
2018-11-01
Completion
2018-11-02

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03266419 on ClinicalTrials.gov